- Financial Statement Quarter 2/2025 (Reviewed)

- Financial Performance Quarter 2 (F45) (Reviewed)

- Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025

- Notification of the Passing of the Chairman of the Board of Directors

- Report on the results of the Exercise of BRR-W2 (9th Exercise) (F53-5)

- Notification of the Intention to Exercise the Warrant to Purchase Ordinary Shares (BRR-W2) (9th Exercise)

- Notification the exercise of BRR-W2 (9th Exercise)

- Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025

- Financial Performance Quarter 1 (F45) (Reviewed)

- Financial Statement Quarter 1/2025 (Reviewed)

- Publication of the Minutes of 2025 Annual General Meeting of Shareholders on the Company's Website

- No Right Adjustment of BRR-W2

- Shareholders meeting's resolution

- Report on the results of the Exercise of BRR-W2 (F53-5) (Revised 2)

- Report on the results of the Exercise of BRR-W2 (F53-5) (Revised)

- Report on the results of the Exercise of BRR-W2 (F53-5)

- Publication of the Invitation Letter for 2025 Annual General Meeting of Shareholders on the Company's Website

- Notification of the Intention to Exercise the Warrant to Purchase Ordinary Shares (BRR-W2) (8th Exercise)

- Notification the exercise of BRR-W2

- Resolutions of the Board of Directors' Meeting on the appointment to replace the retiring director, Dividend Payment and Schedule for Annual General Meeting of Shareholders 2025